Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Study on the Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

NCT06855537 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT06855537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Study on the Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
Lead sponsor
Beijing Anzhen Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
November 3, 2025
Completion date
September 1, 2027
Enrollment
2,190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes (acs), coronary arterial disease (cad), thin-cap fibroatheroma, vulnerable coronary plaques